Furosemide
- Product NDC
- 53002-4300
- 11-digit product format
- 530024300
- Labeler code
- 53002
- Product ID
- 53002-4300_14a27979-0ea5-4512-83ad-ef575881d869
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077293
- Marketing category
- ANDA
- Marketing start
- 2006-02-01
- Marketing end
- 0000-00-00
- Substance
- FUROSEMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-4300-0 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-3 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-0 | 2023-06-07 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-3 | 2023-06-07 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-0 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-3 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-0 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-3 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
| 53002-4300-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-17ad-f424-e053-dadaa90a57ce | FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-4300-0 | Furosemide | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 53002-4300-3 | Furosemide | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-4300 | FUROSEMIDE (FUROSEMIDE) TABLET [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 2 package rows | 20230609_865cd360-30af-43b9-a0b9-f90bbc94624f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-4300-0 | 53002430000 | 100 TABLET in 1 BOTTLE (53002-4300-0) | 100 tablet | 2017-10-01 | 0000-00-00 | No | No | Current |
| 53002-4300-3 | 53002430003 | 30 TABLET in 1 BOTTLE (53002-4300-3) | 30 tablet | 2017-10-01 | 0000-00-00 | No | No | Current |